Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Reg FD DisclosureItem 7.01 · 8-KLOW RiskNeutral

Cognition Therapeutics, Inc.

Filed: Jun 4, 2026CIK: 001-40886Health Care
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Cognition Therapeutics filed an 8-K on June 4, 2026 to disclose an investor presentation attached as Exhibit 99.1, intended for communications with investors and analysts in compliance with Regulation FD requirements.

Key Takeaways

Company filed a Form 8-K under Item 7.01 to disclose a presentation for investor communications

The presentation is attached as Exhibit 99.1 and is not formally filed under the Securities Exchange Act of 1934

2 more takeaways

Filing Overview

Form Type8-K
Filing DateJun 4, 2026
Item7.01
CategoryReg FD Disclosure
CIK001-40886
Accession #0001455365
Risk LevelLOW
SentimentNeutral
Signalinformational
Topics
regulatory

What This Means

The company is making a public disclosure under Regulation FD, often sharing material information to ensure equal access.
View Full Filing on SEC.govBrowse More Filings